Home » Topics » Regulatory » BARDA

BARDA
RSS

BARDA deal could provide T2 Biosystems up to $69M

Sep. 16, 2019

By Meg Bryant

No Comments

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 20, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 20, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe

BARDA RSS

BARDA
RSS